NCT02711969 2022-07-22
A Study of Apatinib Mesylate (YN968D1) 1,000mg in Gastric Cancer Patient Failed to Standard Treatment
Bukwang Pharmaceutical
Phase 1 Completed
Clinical Trials
3 trialsNCT03276156 2017-09-08
Apatinib in Combination With S-1 as Second-Line Treatment in Patients With Advanced Gastric Cancer
Zhejiang Cancer Hospital
Phase 1 Unknown
NCT03026881 2017-03-07
A Study of Fluzoparib Given in Combination With Apatinib and Paclitaxel in Gastric Cancer Patients
Jiangsu HengRui Medicine Co., Ltd.
Phase 1 Unknown